1. Oztekin O, Ozan E, Hilal Adibelli Z, Unal G, Abali Y. SSH-EPI diffusion-weighted MR imaging of the spine with low b values: is it useful in differentiating malignant metastatic tumor infiltration from benign fracture edema? Skeletal Radiol. 2009; 38:651–658.
2. Kim YP, Kannengiesser S, Paek MY, Kim S, Chung TS, Yoo YH, et al. Differentiation between focal malignant marrow-replacing lesions and benign red marrow deposition of the spine with T2*-corrected fat-signal fraction map using a three-echo volume interpolated breath-hold gradient echo Dixon sequence. Korean J Radiol. 2014; 15:781–791.
3. Herneth AM, Philipp MO, Naude J, Funovics M, Beichel RR, Bammer R, et al. Vertebral metastases: assessment with apparent diffusion coefficient. Radiology. 2002; 225:889–894.
4. Baur A, Stäbler A, Brüning R, Bartl R, Krödel A, Reiser M, et al. Diffusion-weighted MR imaging of bone marrow: differentiation of benign versus pathologic compression fractures. Radiology. 1998; 207:349–356.
5. Castillo M. Diffusion-weighted imaging of the spine: is it reliable? AJNR Am J Neuroradiol. 2003; 24:1251–1253.
6. Phalke VV, Gujar S, Quint DJ. Comparison of 3.0 T versus 1.5 T MR: imaging of the spine. Neuroimaging Clin N Am. 2006; 16:241–248. ix
7. Ahlawat S, Khandheria P, Subhawong TK, Fayad LM. Differentiation of benign and malignant skeletal lesions with quantitative diffusion weighted MRI at 3T. Eur J Radiol. 2015; 84:1091–1097.
8. Kuhl CK, Textor J, Gieseke J, von Falkenhausen M, Gernert S, Urbach H, et al. Acute and subacute ischemic stroke at high-field-strength (3.0-T) diffusion-weighted MR imaging: intraindividual comparative study. Radiology. 2005; 234:509–516.
9. Rosner B. Fundamentals of biostatistics. 6th ed. Belmont, CA: Duxbury Press;2005.
10. Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005; 37:360–363.
11. Tang G, Liu Y, Li W, Yao J, Li B, Li P. Optimization of b value in diffusion-weighted MRI for the differential diagnosis of benign and malignant vertebral fractures. Skeletal Radiol. 2007; 36:1035–1041.
12. Lang P, Wendland MF, Saeed M, Gindele A, Rosenau W, Mathur A, et al. Osteogenic sarcoma: noninvasive in vivo assessment of tumor necrosis with diffusion-weighted MR imaging. Radiology. 1998; 206:227–235.
13. Spuentrup E, Buecker A, Adam G, van Vaals JJ, Guenther RW. Diffusion-weighted MR imaging for differentiation of benign fracture edema and tumor infiltration of the vertebral body. AJR Am J Roentgenol. 2001; 176:351–358.
14. Castillo M, Arbelaez A, Smith JK, Fisher LL. Diffusion-weighted MR imaging offers no advantage over routine noncontrast MR imaging in the detection of vertebral metastases. AJNR Am J Neuroradiol. 2000; 21:948–953.
15. Balliu E, Vilanova JC, Peláez I, Puig J, Remollo S, Barceló C, et al. Diagnostic value of apparent diffusion coefficients to differentiate benign from malignant vertebral bone marrow lesions. Eur J Radiol. 2009; 69:560–566.
16. Geith T, Schmidt G, Biffar A, Dietrich O, Dürr HR, Reiser M, et al. Comparison of qualitative and quantitative evaluation of diffusion-weighted MRI and chemical-shift imaging in the differentiation of benign and malignant vertebral body fractures. AJR Am J Roentgenol. 2012; 199:1083–1092.
17. Dietrich O, Biffar A, Reiser MF, Baur-Melnyk A. Diffusion-weighted imaging of bone marrow. Semin Musculoskelet Radiol. 2009; 13:134–144.
18. Lee SY, Jee WH, Jung JY, Park MY, Kim SK, Jung CK, et al. Differentiation of malignant from benign soft tissue tumours: use of additive qualitative and quantitative diffusion-weighted MR imaging to standard MR imaging at 3.0 T. Eur Radiol. 2016; 26:743–754.
19. Subhawong TK, Jacobs MA, Fayad LM. Diffusion-weighted MR imaging for characterizing musculoskeletal lesions. Radiographics. 2014; 34:1163–1177.
20. Yuan YH, Xiao EH, He Z, Xiang J, Tang KL, Yan RH, et al. MR diffusion-weighed imaging of rabbit liver. World J Gastroenterol. 2005; 11:5506–5511.